Phibro Animal Health PE ratio PAHC
Share price divided by earnings per share over the last twelve months, since 2014.
- Today, Oct 23, 2026
- 15.9×
- 10-year median
- 21.5×
- Against its 10-year history
- 20th
- percentile: 0 is its lowest day, 100 its highest
- 10-year range
- 10.6× to 401×
- Peer median
- 12.5×
Phibro Animal Health's PE ratio is 15.9× as of Oct 23, 2026: a share price of $38.80 against $2.44 of earnings per share over the last twelve months.
That is below its ten-year median of 21.5×, lower than on 80% of days in the last ten years.
Over that time it ranged from 10.6× in Oct 2022 to 401× in Oct 2024.
The median for 10 large drugmakers of a similar size is 12.5×.
PE ratio over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 15.9× | 13.2× | 25.7× |
| 2025 | 23.0× | 22.4× | 53.7× |
| 2024 | 49.0× | 20.8× | 401× |
| 2023 | 22.7× | 12.0× | 22.7× |
| 2022 | 11.7× | 10.6× | 17.6× |
| 2021 | 17.0× | 16.0× | 28.2× |
| 2020 | 18.3× | 16.5× | 30.4× |
| 2019 | 24.5× | 15.3× | 24.5× |
| 2018 | 19.7× | 19.6× | 35.5× |
| 2017 | 19.7× | 14.3× | 24.6× |
| 2016 | 15.4× | 9.5× | 22.6× |
| 2015 | 20.0× | 20.0× | 90.7× |
| 2014 | 90.3× | 87.5× | 94.0× |
Against its peers
Companies in Drug Manufacturers - General nearest Phibro Animal Health's size, closest first, today.
| Company | PE ratio |
|---|---|
| PAHCPhibro Animal Health | 15.9× |
| ANIPANI Pharmaceuticals | 15.4× |
| ANABAnaptysbio | 10.7× |
| PCRXPacira BioSciences | 104× |
| OMEROmeros | 10.9× |
| HRMYHarmony Biosciences | 11.7× |
| PBHPrestige Consumer Healthcare | 13.4× |
| AMPHAmphastar Pharmaceuticals | 14.8× |
| NRIXNurix Therapeutics | 11.0× |
| ABUSArbutus Biopharma | 5.4× |
| COLLCollegium Pharmaceutical | 18.5× |
| Peer median | 12.5× |
Where Phibro Animal Health ranks
What the PE ratio tells you
Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.
Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.
More on Phibro Animal Health
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.